# AstraZeneca outlined plans to invest 300 million pounds ($405.5 million) in the U.K. The move reverses AstraZeneca's decision to pause planned investments in its home country last year.

*biotech · news · 2026-04-29 · MarketScreener*

## Key points

- AstraZeneca is investing £300 million in the UK after pausing local investment last year.
- The renewed UK investment follows a drug-pricing deal between the UK and US to boost pharma spending.
- AstraZeneca's oncology unit now makes up 44% of total revenue and dominates its late-stage pipeline.
- Company revenue and core earnings for Q1 both exceeded analyst forecasts, driven by cancer drug demand.
- UK pharma investment commitments since December are £1.575 billion, spurred by the UK-US pharma deal.

**Companies:** AstraZeneca
**Countries:** United Kingdom, United States, China

[Read the full story on MarketScreener](https://www.marketscreener.com/news/astrazeneca-plans-u-k-investment-as-cancer-drugs-lift-revenue-update-ce7f58dadb8ff32c)

---

Canonical: https://newsio.io/n/48b96208-cf07-48d8-9157-4d9de5bdf90d/astrazeneca-outlined-plans-to-invest-300-million-pounds-405-5-million-in-the-u-k
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works